scPharmaceuticals
SCPH
SCPH
40 hedge funds and large institutions have $60M invested in scPharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
40
Holders Change
+2
Holders Change %
+5.26%
% of All Funds
0.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
9
Reduced
15
Closed
2
Calls
$131K
Puts
$82K
Net Calls
+$49K
Net Calls Change
+$49K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
State Street
Boston,
Massachusetts
| $113K | – | – | – |
|
27
Commonwealth Equity Services
Waltham,
Massachusetts
| $101K | – | – | – |
|
|
RWM
28
Ritholtz Wealth Management
New York
| $98K | +$98K | +15,000 | New |
|
|
IIA
29
IPG Investment Advisors
San Diego,
California
| $93.2K | – | – | – |
|
30
Envestnet Asset Management
Chicago,
Illinois
| $92K | +$92K | +14,186 | New |
|
|
CSS
31
Cubist Systematic Strategies
Stamford,
Connecticut
| $75K | +$75K | +11,573 | New |
|
|
SCA
32
Sandy Cove Advisors
Hingham,
Massachusetts
| $69K | – | – | – |
|
|
TRCT
33
Tower Research Capital (TRC)
New York
| $52K | +$9.86K | +1,520 | +23% |
|
34
Osaic Holdings
Scottsdale,
Arizona
| $32K | +$14.7K | +2,263 | +85% |
|
|
O
35
OrbiMed
New York
| $31.3K | – | – | – |
|
36
Bank of America
Charlotte,
North Carolina
| $7K | – | – | – |
|
37
Fidelity Investments
Boston,
Massachusetts
| $5K | – | – | – |
|
38
BNP Paribas Financial Markets
Paris,
France
| $691 | – | – | – |
|
|
VF
39
Virtu Financial
New York
| – | -$53K | -10,999 | Closed |
|
40
UBS Group
Zurich,
Switzerland
| – | -$10K | -2,152 | Closed |
|